This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
ZNF524 directly interacts with telomeric DNA and supports telomere integrity
Nature Communications Open Access 12 December 2023
-
DNA polymerases in precise and predictable CRISPR/Cas9-mediated chromosomal rearrangements
BMC Biology Open Access 08 December 2023
-
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo
Leukemia Open Access 18 July 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hsu, P.D., Lander, E.S. & Zhang, F. Cell 157, 1262–1278 (2014).
Zetsche, B. et al. Cell 163, 759–771 (2015).
Charpentier, E. & Doudna, J.A. Nature 495, 50–51 (2013).
Ran, F.A. et al. Cell 154, 1380–1389 (2013).
Gagnon, J.A. et al. PLoS One 9, e98186 (2014).
Guell, M., Yang, L. & Church, G.M. Bioinformatics 30, 2968–2970 (2014).
Pinello, L., Canver, M., Hoban, M. & Orkin, S. CRISPResso: sequencing analysis toolbox for CRISPR-Cas9 genome editing. Preprint at bioRxiv http://www.biorxiv.org/content/early/2015/11/10/031203 (2015).
Yen, S.T. et al. Dev. Biol. 393, 3–9 (2014).
Yoshimi, K., Kaneko, T., Voigt, B. & Mashimo, T. Nat. Commun. 5, 4240 (2014).
Shah, A.N., Davey, C.F., Whitebirch, A.C., Miller, A.C. & Moens, C.B. Nat. Methods 12, 535–540 (2015).
McCarthy, D.J. et al. Genome Med. 6, 26 (2014).
Li, H. Bioinformatics 30, 2843–2851 (2014).
O'Rawe, J. et al. Genome Med. 5, 28 (2013).
Varshney, G., Pei, W., LaFave, M. & Idol, J. Genome Res. 25, 1030–1042 (2015).
Moreno-Mateos, M.A. et al. Nat. Methods 12, 982–988 (2015).
Kent, W.J. Genome Res. 12, 656–664 (2002).
Huber, W. et al. Nat. Methods 12, 115–121 (2015).
Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv 3 (2013). http://arxiv.org/abs/1303.3997.
Hill, J., Demarest, B. & Hill, M. Package 'sangerseqR' (2014).
Lawrence, M. et al. PLOS Comput. Biol. 9, e1003118 (2013).
Burger, A. et al. Maximizing mutagenesis with solubilized CRISPR-Cas9 ribonucleoprotein complexes. Development 143, 2025–2037 (2016).
Cho, S.W. et al. Genome Res. 24, 132–141 (2014).
Acknowledgements
This work was supported by the Canton of Zürich, a Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNSF) professorship (PP00P3_139093), a Marie Curie Career Integration Grant from the European Commission, and a Schweizerische Herzstiftung grant to C.M.; European Research Council Starting Grant ANTIVIRNA (337284) and an SNSF Project Grant (31003A_149393) to M.J.; a European Commission 7th Framework Collaborative Project RADIANT grant (agreement number 305626) and an SNSF Project Grant (31003A_143883) to M.D.R.; a Universität Zürich (UZH) URPP Translational Cancer Research Seed Grant to A.B.; and a UZH Forschungskredit to C.H.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Additional information
Editor's note: This article has been peer reviewed.
Supplementary information
Supplementary Figures and Texts
Supplementary Figures and Notes (PDF 834 kb)
Supplementary Information
Supplementary Software (TAR 2794 kb)
Rights and permissions
About this article
Cite this article
Lindsay, H., Burger, A., Biyong, B. et al. CrispRVariants charts the mutation spectrum of genome engineering experiments. Nat Biotechnol 34, 701–702 (2016). https://doi.org/10.1038/nbt.3628
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3628
This article is cited by
-
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1
EMBO Molecular Medicine (2024)
-
DNA polymerases in precise and predictable CRISPR/Cas9-mediated chromosomal rearrangements
BMC Biology (2023)
-
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo
Leukemia (2023)
-
Lipid droplets are a metabolic vulnerability in melanoma
Nature Communications (2023)
-
ZNF524 directly interacts with telomeric DNA and supports telomere integrity
Nature Communications (2023)